Combining gene expression signatures and autoantibody profiles in human meningioma.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 184, doi. 10.1038/gt.2008.130
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2009 AND VI 16 AND IP 2
Results: 15
1
2
Mechanisms of distribution of mouse β-galactosidase in the adult GM1-gangliosidosis brain.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 303, doi. 10.1038/gt.2008.149
- By:
- Publication type:
- Article
3
Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 211, doi. 10.1038/gt.2008.150
- By:
- Publication type:
- Article
4
Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 218, doi. 10.1038/gt.2008.152
- By:
- Publication type:
- Article
5
Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 297, doi. 10.1038/gt.2008.154
- By:
- Publication type:
- Article
6
Controlled propagation of replication-competent Sindbis viral vector using suicide gene strategy.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 291, doi. 10.1038/gt.2008.153
- By:
- Publication type:
- Article
7
The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr<sup>−/−</sup>-dependent allergy mouse model.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 172, doi. 10.1038/gt.2008.156
- By:
- Publication type:
- Article
8
An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 229, doi. 10.1038/gt.2008.158
- By:
- Publication type:
- Article
9
Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 279, doi. 10.1038/gt.2008.159
- By:
- Publication type:
- Article
10
Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 252, doi. 10.1038/gt.2008.160
- By:
- Publication type:
- Article
11
Complete elimination of established neuroblastoma by synergistic action of γ-irradiation and DCs treated with rSeV expressing interferon-β gene.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 240, doi. 10.1038/gt.2008.161
- By:
- Publication type:
- Article
12
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 262, doi. 10.1038/gt.2008.165
- By:
- Publication type:
- Article
13
Antigen-specific humoral tolerance or immune augmentation induced by intramuscular delivery of adeno-associated viruses encoding CTLA4-Ig-antigen fusion molecules.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 200, doi. 10.1038/gt.2008.168
- By:
- Publication type:
- Article
14
A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 190, doi. 10.1038/gt.2008.169
- By:
- Publication type:
- Article
15
Progress and Prospects: The design and production of plasmid vectors.
- Published in:
- Gene Therapy, 2009, v. 16, n. 2, p. 165, doi. 10.1038/gt.2008.183
- By:
- Publication type:
- Article